Transition state stabilization and binding energy use by catalytic antibody 17E8: Studies with alternative substrates

Medicine & Life Sciences

• Catalytic Antibodies 100%
• Catalysis 69%
• Immunoglobulin Fab Fragments 37%
• Immunoglobulin Fragments 36%
• National Institutes of Health (U.S.) 29%
• Esters 29%
• Hydrolysis 26%
• Catalytic Domain 26%
• Proteins 21%
• Kinetics 20%
• Amino Acids 20%
• Antibodies 15%

Chemical Compounds

• Stabilization Energy 68%
• Binding Energy 50%
• Transition State 47%
• Catalysis 18%
• Hydrolysis 8%
• Ester 8%
• Crystal Structure 7%
• Protein 5%
• Acid 4%